Orano Med
Gwenaelle Nourry has held various HR roles throughout their work experience. Gwenaelle started their career as an HR manager at AREVA in 2001 and remained in this position until 2022. From 2017 to 2022, they served as the HR Director at Orano Mining. Currently, they are the HR Director at Orano Med, a position they assumed in October 2022.
Gwenaelle Nourry obtained a Master's Degree in Psychology, Education, and Organization Management from Universite de Dijon from the year 2000 to 2001.
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.